Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 18.91B | 16.49B | 13.52B | 11.22B | 11.82B |
Gross Profit | 4.22B | 3.62B | 2.76B | 2.14B | -210.00M |
EBITDA | 3.48B | 3.74B | 1.29B | 996.00M | -166.00M |
Net Income | 2.52B | 2.41B | -1.19B | 120.00M | -3.17B |
Balance Sheet | |||||
Total Assets | 35.69B | 31.51B | 29.45B | 28.67B | 29.52B |
Cash, Cash Equivalents and Short-Term Investments | 5.36B | 3.52B | 2.40B | 2.55B | 3.42B |
Total Debt | 5.13B | 5.76B | 5.96B | 7.78B | 7.33B |
Total Liabilities | 36.57B | 35.14B | 35.47B | 33.31B | 34.39B |
Stockholders Equity | -912.00M | -3.68B | -6.05B | -4.66B | -4.90B |
Cash Flow | |||||
Free Cash Flow | 2.90B | 1.77B | 1.49B | -587.00M | -3.59B |
Operating Cash Flow | 3.78B | 2.48B | 1.85B | -259.00M | -3.01B |
Investing Cash Flow | -831.00M | -726.00M | 826.00M | -428.00M | -1.01B |
Financing Cash Flow | -1.05B | -549.00M | -2.87B | -88.00M | 3.02B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
73 Outperform | $83.68B | 32.95 | 0.45% | 14.70% | 3.76% | ||
58 Neutral | HK$14.11B | 4.63 | -3.01% | 6.76% | 3.67% | -54.16% | |
― | $73.23B | 31.03 | 17.85% | 1.74% | ― | ― | |
75 Outperform | £1.47B | 38.19 | 11.62% | 1.90% | 8.00% | 674.47% | |
74 Outperform | £5.44B | 22.01 | 49.75% | 0.75% | 3.34% | 481.76% | |
74 Outperform | £767.07M | 30.05 | 5.59% | 1.31% | 1.41% | -16.76% | |
63 Neutral | £2.62B | 17.97 | -23.92% | 1.15% | 1.02% | -240.44% |